Our data suggest increased PH inhibition as a promising tool for a customized upregulation of SDF-1 and CXCR4 expression to attract reparative CXCR4+/CD11b+ cells to the ischemic heart associated with increased cardiac repair. This evidence concerns the gene CXCR4 and benign neoplasm.